Astri Therapeutics Inc (ATXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Operating Expenses | 9,507 | 7,898 | 7,486 | 170,085 | 8,977 |
Operating Income | -9,507 | -7,898 | -7,486 | -170,085 | -8,977 |
Other Income | 16 | 27 | 20 | 1 | -1 |
Pre-tax Income | -9,491 | -7,871 | -7,466 | -170,084 | -8,978 |
Net Income Continuous | -9,491 | -7,871 | -7,466 | -170,084 | -8,978 |
Net Income | $-9,491 | $-7,871 | $-7,466 | $-170,084 | $-8,978 |
EPS Basic Total Ops | 26.96 | -0.61 | -5.33 | -45.60 | -2.66 |
EPS Basic Continuous Ops | 25.62 | -0.61 | -1.25 | -45.60 | -2.67 |
EPS Diluted Total Ops | 26.96 | -0.61 | -5.33 | -45.60 | -2.66 |
EPS Diluted Continuous Ops | 25.62 | -0.61 | -1.25 | -45.60 | -2.67 |
EBITDA(a) | $-9,507 | $-7,898 | $-7,486 | $-170,085 | $-8,977 |